Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 16, Issue 17

2024 September-1 - 191 articles

Cover Story: Quadruplet induction regimens for patients with treatment-naïve, newly diagnosed multiple myeloma have shown impressive results in multiple trials. However, trials of 4-drug regimens typically use a 3-drug regimen as their comparator, limiting the ability to determine whether the benefit is from the specific combination or just the addition of more agents. We performed a meta-analysis of all trials that randomized patients into a 4-drug vs. 3-drug induction regimens. Our dataset included 11 trials (representing 6509 unique patients) with a goal of determining the PFS and OS benefit, if any, of a 4-drug combination. We also evaluated the toxicity profile of these regimens, recognizing that the addition of more agents to induction regimens may result in more adverse effects. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (191)

  • Article
  • Open Access
1,745 Views
12 Pages

Clinical Interest in Exome-Based Analysis of Somatic Mutational Signatures for Non-Small Cell Lung Cancer

  • Morgane Peroz,
  • Hugo Mananet,
  • Nicolas Roussot,
  • Courèche Guillaume Kaderbhai,
  • Valentin Derangère,
  • Caroline Truntzer and
  • François Ghiringhelli

9 September 2024

Background: Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality. This study investigates the clinical interest of whole exome sequencing (WES) for analyzing somatic mutational signatures in patients with advanced...

  • Article
  • Open Access
1,531 Views
11 Pages

The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies

  • Maria Dąbrowska,
  • Jerzy Jaroszewicz,
  • Marek Sitko,
  • Justyna Janocha-Litwin,
  • Dorota Zarębska-Michaluk,
  • Ewa Janczewska,
  • Beata Lorenc,
  • Magdalena Tudrujek-Zdunek,
  • Anna Parfieniuk-Kowerda and
  • Robert Flisiak
  • + 7 authors

9 September 2024

Background: Over the past years, the introduction of direct-acting antivirals (DAAs) revolutionized chronic hepatitis C treatment. We aimed to characterize and assess treatment efficacy in three specific groups of patients treated with DAAs: those wi...

  • Review
  • Open Access
2 Citations
4,028 Views
25 Pages

Cellular and Microbial In Vitro Modelling of Gastrointestinal Cancer

  • Kristina Žukauskaitė,
  • Melissa Li,
  • Angela Horvath,
  • Sonata Jarmalaitė and
  • Vanessa Stadlbauer

9 September 2024

Human diseases are multifaceted, starting with alterations at the cellular level, damaging organs and their functions, and disturbing interactions and immune responses. In vitro systems offer clarity and standardisation, which are crucial for effecti...

  • Perspective
  • Open Access
6 Citations
3,091 Views
17 Pages

Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group

  • Nam P. Nguyen,
  • Brandi R. Page,
  • Huan Giap,
  • Zineb Dahbi,
  • Vincent Vinh-Hung,
  • Olena Gorobets,
  • Mohammad Mohammadianpanah,
  • Micaela Motta,
  • Maurizio Portaluri and
  • Alexander Chi
  • + 11 authors

9 September 2024

The standard of care for locally advanced non-small-cell lung cancer (NSCLC) is either surgery combined with chemotherapy pre- or postoperatively or concurrent chemotherapy and radiotherapy. However, older and frail patients may not be candidates for...

  • Review
  • Open Access
8 Citations
4,781 Views
25 Pages

The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer

  • Sebastian Curcean,
  • Andra Curcean,
  • Daniela Martin,
  • Zsolt Fekete,
  • Alexandru Irimie,
  • Alina-Simona Muntean and
  • Cosmin Caraiani

9 September 2024

The role of magnetic resonance imaging (MRI) in rectal cancer management has significantly increased over the last decade, in line with more personalized treatment approaches. Total neoadjuvant treatment (TNT) plays a pivotal role in the shift from t...

  • Article
  • Open Access
1 Citations
2,099 Views
15 Pages

Rhabdomyosarcoma of the Biliary Tract in Children: Analysis of Single Center Experience

  • Ewa Święszkowska,
  • Dorota Broniszczak,
  • Piotr Kaliciński,
  • Marek Szymczak,
  • Marek Stefanowicz,
  • Wiesława Grajkowska and
  • Bożenna Dembowska-Bagińska

9 September 2024

Rhabdomyosarcoma (RMS) of the biliary tract is a rare tumor in children, constituting 0.5–0.8% of all pediatric RMS. Still, it is the most common malignancy in this location in children. Due to its rarity and location, it may cause diagnostic a...

  • Review
  • Open Access
2,222 Views
11 Pages

9 September 2024

Even if its completed form is complex, cancer originates from one or two events that happened to a single cell. A simplified model can play a role in understanding how cancer initiates at the beginning. The pathophysiology of leukemia has been studie...

  • Article
  • Open Access
4 Citations
2,326 Views
19 Pages

Curcumin-Dichloroacetate Hybrid Molecule as an Antitumor Oral Drug against Multidrug-Resistant Advanced Bladder Cancers

  • Kunj Bihari Gupta,
  • Truett L. Taylor,
  • Siva S. Panda,
  • Muthusamy Thangaraju and
  • Bal. L. Lokeshwar

8 September 2024

Tumor cells produce excessive reactive oxygen species (ROS) but cannot detoxify ROS if they are due to an external agent. An agent that produces toxic levels of ROS, specifically in tumor cells, could be an effective anticancer drug. CMC-2 is a molec...

  • Systematic Review
  • Open Access
2 Citations
3,969 Views
13 Pages

8 September 2024

Over the past decade, SLN mapping has become increasingly important in cervical cancer surgery. ICG is the most commonly used tracer due to its high bilateral detection rates, ease of use, and safety. However, there is no consensus on the optimal ICG...

  • Commentary
  • Open Access
6 Citations
3,944 Views
13 Pages

8 September 2024

Cell division is crucial for the survival of living organisms. Human cells undergo three types of cell division: mitosis, meiosis, and amitosis. The former two types occur in somatic cells and germ cells, respectively. Amitosis involves nuclear buddi...

  • Article
  • Open Access
2 Citations
2,367 Views
13 Pages

Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature

  • Alexandra Pușcașu,
  • Fabien Moinard-Butot,
  • Simon Nannini,
  • Cathie Fischbach,
  • Roland Schott and
  • Laura Bender

8 September 2024

In the era of immune checkpoint inhibitors (ICI), managing non-oncogene driven non-small cell lung cancer (NSCLC) with brain metastases (BM) is challenging, especially when brain involvement is the initial sign. Patients with newly diagnosed brain me...

  • Article
  • Open Access
2,323 Views
20 Pages

Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors

  • Sabah Alaklabi,
  • Orla Maguire,
  • Harsha Pattnaik,
  • Yali Zhang,
  • Jacky Chow,
  • Jianmin Wang,
  • Hans Minderman and
  • Renuka Iyer

7 September 2024

The CLARINET trial led to the approval of lanreotide for the treatment of patients with gastroenteropancreatic neuroendocrine tumors (NETs). It is hypothesized that lanreotide regulates proliferation, hormone synthesis, and other cellular functions v...

  • Article
  • Open Access
9 Citations
3,053 Views
23 Pages

7 September 2024

We showed previously that the autocrine activation of the FGFR-mediated pathway in GIST lacking secondary KIT mutations was a result of the inhibition of KIT signaling. We show here that the FGF2/FGFR pathway regulates VEGF-A/VEGFR signaling in IM-re...

  • Article
  • Open Access
3 Citations
2,245 Views
11 Pages

7 September 2024

Introduction: Maximal heterozygosity on the human leukocyte antigen (HLA) loci has been found to be associated with improved survival and development of immune-related adverse events (irAEs) among NSCLC patients treated with immunotherapy. Here, we i...

  • Article
  • Open Access
2 Citations
2,493 Views
12 Pages

6 September 2024

Primarily, breast-conserving therapy is an oncological intervention, but eventually it is judged by its cosmetic result. Remaining cavities from tumor resection can promote seromas, delay healing and cause lasting discomfort. Additionally, volume los...

  • Review
  • Open Access
4 Citations
9,186 Views
26 Pages

6 September 2024

Spatial transcriptomics (ST) examines gene expression within its spatial context on tissue, linking morphology and function. Advances in ST resolution and throughput have led to an increase in scientific interest, notably in cancer research. This sco...

  • Review
  • Open Access
8 Citations
6,461 Views
18 Pages

6 September 2024

There is an unmet need to develop new treatments for metastatic prostate cancer. With the development of targeted radioligand therapies, bispecific T cell engagers, antibody–drug conjugates and chimeric antigen receptor T cell (CAR T) therapies...

  • Article
  • Open Access
1 Citations
2,843 Views
12 Pages

Deep Learning Model for Predicting Lung Adenocarcinoma Recurrence from Whole Slide Images

  • Ziyu Su,
  • Usman Afzaal,
  • Shuo Niu,
  • Margarita Munoz de Toro,
  • Fei Xing,
  • Jimmy Ruiz,
  • Metin N. Gurcan,
  • Wencheng Li and
  • M. Khalid Khan Niazi

6 September 2024

Lung cancer is the leading cause of cancer-related death in the United States. Lung adenocarcinoma (LUAD) is one of the most common subtypes of lung cancer that can be treated with resection. While resection can be curative, there is a significant ri...

  • Review
  • Open Access
6 Citations
4,636 Views
11 Pages

6 September 2024

The use of radioactive iodine (RAI) after total thyroidectomy for patients at the American Thyroid Association (ATA) who are at intermediate risk of recurrence is controversial. This is due to the lack of prospective randomized trials proving a benef...

  • Article
  • Open Access
6 Citations
3,169 Views
11 Pages

Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma

  • Gabriele Roccuzzo,
  • Paolo Fava,
  • Chiara Astrua,
  • Matteo Giovanni Brizio,
  • Giovanni Cavaliere,
  • Eleonora Bongiovanni,
  • Umberto Santaniello,
  • Giulia Carpentieri,
  • Luca Cangiolosi and
  • Pietro Quaglino
  • + 3 authors

6 September 2024

This study was carried out at the Dermatologic Clinic of the University of Turin, Italy, to assess the effectiveness and safety of adjuvant therapy in patients who received either targeted therapy (TT: dabrafenib + trametinib) or immunotherapy (IT: n...

  • Article
  • Open Access
5 Citations
3,169 Views
16 Pages

A Comprehensive Analysis of Skin Cancer Concerns and Protective Practices in Manitoba, Canada, Highlights Lack of Skin Cancer Awareness and Predominance of High-Risk Sun Exposure Behaviors

  • François Lagacé,
  • Santina Conte,
  • Lorena A. Mija,
  • Amina Moustaqim-Barrette,
  • Farhan Mahmood,
  • Jonathan LeBeau,
  • Alyson McKenna,
  • Mahan Maazi,
  • Johnny Hanna and
  • Ivan V. Litvinov
  • + 4 authors

5 September 2024

The rapidly increasing skin cancer rates in Canada are alarming, with current data estimating that 1/3 of Canadians will be affected in their lifetime. Thus, deeper understanding of high-risk sun exposure behaviors is needed to help counter this tren...

  • Review
  • Open Access
3 Citations
4,210 Views
16 Pages

Transdermal Fentanyl in Patients with Cachexia—A Scoping Review

  • Andrea Carlini,
  • Emanuela Scarpi,
  • Carla Bettini,
  • Andrea Ardizzoni,
  • Costanza Maria Donati,
  • Laura Fabbri,
  • Francesca Ghetti,
  • Francesca Martini,
  • Marianna Ricci and
  • Romina Rossi
  • + 5 authors

5 September 2024

Cachectic patients frequently require transdermal fentanyl (TDF) for pain management, but data on its efficacy and safety are scarce and inconsistent. This scoping review aims to analyze the evidence concerning TDF administration in patients with cac...

  • Article
  • Open Access
6 Citations
2,813 Views
17 Pages

5 September 2024

Pancreatic cancer is a refractory cancer with limited treatment options. Various cancer types are resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Eugenol, the main component of clove oil, exhibits anticancer, anti-inflam...

  • Article
  • Open Access
1 Citations
2,278 Views
12 Pages

5 September 2024

Single-port robotic-assisted thoracic surgery (SP-RATS) lobectomy using the da Vinci Xi system has been performed by several pioneers. However, due to the severe collisions and the steep learning curve, this approach is not yet widely used. This stud...

  • Article
  • Open Access
5 Citations
4,745 Views
20 Pages

Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling

  • Renu Wadhwa,
  • Jia Wang,
  • Seyad Shefrin,
  • Huayue Zhang,
  • Durai Sundar and
  • Sunil C. Kaul

5 September 2024

Survivin, a member of the IAP family, functions as a homodimer and inhibits caspases, the key enzymes involved in apoptosis. Several Survivin inhibitors, including YM-155, Debio1143, EM1421, LQZ-7I, and TL32711, have emerged as potential anticancer d...

  • Review
  • Open Access
11 Citations
5,176 Views
18 Pages

Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion

  • Navid Sobhani,
  • Alberto D’Angelo,
  • Matteo Pittacolo,
  • Giuseppina Mondani and
  • Daniele Generali

5 September 2024

The medical research field has been tremendously galvanized to improve the prediction of therapy efficacy by the revolution in artificial intelligence (AI). An earnest desire to find better ways to predict the effectiveness of therapy with the use of...

  • Review
  • Open Access
15 Citations
3,295 Views
15 Pages

5 September 2024

Minimally invasive thoracic surgery has advanced the treatment of lung cancer since its introduction in the 1990s. Video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery (RATS) offer the advantage of smaller incisions witho...

  • Article
  • Open Access
1 Citations
2,643 Views
15 Pages

Exposed Phosphatidylserine as a Biomarker for Clear Identification of Breast Cancer Brain Metastases in Mouse Models

  • Lulu Wang,
  • Alan H. Zhao,
  • Chad A. Arledge,
  • Fei Xing,
  • Michael D. Chan,
  • Rolf A. Brekken,
  • Amyn A. Habib and
  • Dawen Zhao

5 September 2024

Brain metastasis is the most common intracranial malignancy in adults. The prognosis is extremely poor, partly because most patients have more than one brain lesion, and the currently available therapies are nonspecific or inaccessible to those occul...

  • Review
  • Open Access
3 Citations
5,243 Views
10 Pages

Clinical and Histologic Variants of CD8+ Cutaneous T-Cell Lymphomas

  • Madisen A. Swallow,
  • Goran Micevic,
  • Amanda Zhou,
  • Kacie R. Carlson,
  • Francine M. Foss and
  • Michael Girardi

5 September 2024

Although the vast majority of CTCL subtypes are of the CD4+ T-helper cell differentiation phenotype, there is a spectrum of CD8+ variants that manifest wide-ranging clinical, histologic, and phenotypic features that inform the classification of the d...

  • Article
  • Open Access
3 Citations
4,204 Views
11 Pages

Analysis of the Performance and Accuracy of a PSA and PSA Ratio-Based Nomogram to Predict the Probability of Prostate Cancer in a Cohort of Patients with PIRADS 3 Findings at Multiparametric Magnetic Resonance Imaging

  • Franco Palmisano,
  • Vito Lorusso,
  • Rebecca Legnani,
  • Vincenzo Martorello,
  • Carlotta Nedbal,
  • Pietro Tramanzoli,
  • Federica Marchesotti,
  • Simona Ferraro,
  • Michele Talso and
  • Andrea Gregori
  • + 3 authors

5 September 2024

Background: PIRADS score 3 represents a challenge in prostate cancer (PCa) detection with MRI. Our study aimed to evaluate the application of a nomogram on a cohort of patients with PIRADS 3. Methods: We analyzed 286 patients undergoing fusion prosta...

  • Review
  • Open Access
4 Citations
9,842 Views
26 Pages

5 September 2024

Nicotinamide adenine dinucleotide (NAD+) is an important cofactor for both metabolic and signaling pathways, with the dysregulation of NAD+ levels acting as a driver for diseases such as neurodegeneration, cancers, and metabolic diseases. NAD+ plays...

  • Review
  • Open Access
11 Citations
6,809 Views
18 Pages

4 September 2024

The management of advanced cutaneous squamous cell carcinoma (CSCC) has been revolutionized by the introduction of immunotherapy. Yet, successful treatment with immunotherapy relies on an adequate antitumor immune response. Patients who are solid-org...

  • Review
  • Open Access
17 Citations
5,367 Views
13 Pages

Cisplatin Resistance and Metabolism: Simplification of Complexity

  • Nikolay V. Pervushin,
  • Maria A. Yapryntseva,
  • Mikhail A. Panteleev,
  • Boris Zhivotovsky and
  • Gelina S. Kopeina

4 September 2024

Cisplatin is one of the most well-known anti-cancer drugs and has demonstrated efficacy against numerous tumor types for many decades. However, a key challenge with cisplatin, as with any chemotherapeutic agent, is the development of resistance with...

  • Article
  • Open Access
3 Citations
1,865 Views
11 Pages

Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment

  • Anna Colomba,
  • Anna Astarita,
  • Giulia Mingrone,
  • Lorenzo Airale,
  • Cinzia Catarinella,
  • Fabrizio Vallelonga,
  • Dario Leone,
  • Marco Cesareo,
  • Arianna Paladino and
  • Alberto Milan
  • + 4 authors

4 September 2024

Multiple myeloma (MM) affects a population with a high prevalence of cardiovascular (CV) disease. These patients benefit from an accurate CV risk evaluation in order to choose the safest drug regimen. Haemodynamic forces (HDFs) analysis allows for th...

  • Article
  • Open Access
2,281 Views
19 Pages

Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy

  • Stefania Moramarco,
  • Luigi De Angelis,
  • Laura Bernardini,
  • Lorenza Marconi,
  • Gaia Piunno,
  • Simonetta Siciliano,
  • Andrea Malizia,
  • Ersilia Buonomo,
  • Alessia Pesaresi and
  • Francesco Torino
  • + 4 authors

4 September 2024

Background: Understanding the specific needs of cancer survivors is essential for healthcare policy. In Italy, dedicated studies are lacking, so we aimed to investigate the physical, mental, social, and health difficulties encountered by these patien...

  • Review
  • Open Access
27 Citations
14,917 Views
43 Pages

Orally Ingested Micro- and Nano-Plastics: A Hidden Driver of Inflammatory Bowel Disease and Colorectal Cancer

  • Annalisa Bruno,
  • Melania Dovizio,
  • Cristina Milillo,
  • Eleonora Aruffo,
  • Mirko Pesce,
  • Marco Gatta,
  • Piero Chiacchiaretta,
  • Piero Di Carlo and
  • Patrizia Ballerini

4 September 2024

Micro- and nano-plastics (MNPLs) can move along the food chain to higher-level organisms including humans. Three significant routes for MNPLs have been reported: ingestion, inhalation, and dermal contact. Accumulating evidence supports the intestinal...

  • Article
  • Open Access
1 Citations
2,215 Views
25 Pages

4 September 2024

Circulating tumor cells (CTCs) are cells that have separated from a solid cancerous lesion and entered the bloodstream. They play a crucial role in driving the metastatic spread to distant organs, which is the leading cause of cancer-related deaths....

  • Article
  • Open Access
1 Citations
2,766 Views
11 Pages

The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi

  • Rosario Agüero,
  • Kendall L. Buchanan,
  • Cristián Navarrete-Dechent,
  • Ashfaq A. Marghoob,
  • Jennifer A. Stein,
  • Michael S. Landy,
  • Sancy A. Leachman,
  • Kenneth G. Linden,
  • Sandra Garcet and
  • Daniel S. Gareau
  • + 1 author

4 September 2024

Incorporation of dermoscopy and artificial intelligence (AI) is improving healthcare professionals’ ability to diagnose melanoma earlier, but these algorithms often suffer from a “black box” issue, where decision-making processes ar...

  • Systematic Review
  • Open Access
2 Citations
4,061 Views
15 Pages

4 September 2024

The purpose of this study was to conduct a systematic review and meta-analysis of case reports presenting HCC spread to the diaphragm muscle and to determine possible risk factors for this condition. An extensive literature search was performed using...

  • Review
  • Open Access
5 Citations
5,367 Views
15 Pages

Therapeutic Advances in Advanced Basal Cell Carcinoma

  • Samer Alkassis,
  • Maya Shatta and
  • Deborah J. Wong

4 September 2024

Basal cell carcinoma (BCC) is the most common type of cancer with an estimated 3.6 million cases diagnosed annually in the US alone. While most cases are treatable with low recurrence rates, 1–10% progress to an advanced stage which can behave...

  • Article
  • Open Access
5 Citations
3,175 Views
9 Pages

Improving the Clinical Utility of Platelet Count for Cancer Detection in Primary Care: A Cohort Study in England, Canada, and Australia

  • Luke T. A. Mounce,
  • Raff Calitri,
  • Willie Hamilton,
  • Meena Rafiq,
  • Jon D. Emery,
  • Vasily Giannakeas,
  • Joanne Kotsopoulos and
  • Sarah E. R. Bailey

4 September 2024

The platelet count, a component of the full blood count, has been identified as a useful diagnostic marker for cancer in primary care. The reference range for the platelet count is 150 to 400 or 450 × 109/L; this range does not account for natu...

  • Article
  • Open Access
5 Citations
4,706 Views
23 Pages

A Patient-Centered Conceptual Model of AYA Cancer Survivorship Care Informed by a Qualitative Interview Study

  • Marlaine S. Figueroa Gray,
  • Lily Shapiro,
  • Caitlin N. Dorsey,
  • Sarah Randall,
  • Mallory Casperson,
  • Neetu Chawla,
  • Brad Zebrack,
  • Monica M. Fujii,
  • Erin E. Hahn and
  • Jessica Chubak
  • + 6 authors

4 September 2024

Purpose: Conceptual models provide frameworks to illustrate relationships among patient-, provider-, system-, and community-level factors that inform care delivery and research. Existing models of cancer survivorship care focus largely on pediatric o...

  • Article
  • Open Access
5 Citations
2,518 Views
10 Pages

4 September 2024

The monarchE study added the CDK4/6 inhibitor abemaciclib to the care of women with oestrogen-positive (ER+) breast cancers. Eligibility required meeting monarchE criteria—either >3 positive axillary nodes, or 1–3 positive sentinel nod...

  • Review
  • Open Access
8 Citations
8,029 Views
21 Pages

4 September 2024

Antibody–drug conjugates (ADCs) consist of an antibody backbone that recognizes and binds to a target antigen expressed on tumor cells and a small molecule chemotherapy payload that is conjugated to the antibody via a linker. ADCs are one of th...

  • Article
  • Open Access
3 Citations
1,779 Views
14 Pages

WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients

  • Semra Aydin,
  • Jennifer Schmitz,
  • Chiara M. Dellacasa,
  • Irene Dogliotti,
  • Luisa Giaccone and
  • Alessandro Busca

4 September 2024

Introduction: Post-transplant relapse of acute myeloid leukemia and myelodysplastic syndrome faces restricted effective salvage regimens. We retrospectively analyzed the use of Azacitidine–donor lymphocyte infusion (AZA/DLI) in this setting. Fu...

  • Review
  • Open Access
36 Citations
16,617 Views
19 Pages

TP53 Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications

  • Chuqi Wang,
  • Jordan Yong Ming Tan,
  • Nishtha Chitkara and
  • Shruti Bhatt

3 September 2024

Mutation in p53 is the most frequent event in cancer development and a leading cause of cancer therapy resistance due to evasion of the apoptosis cascade. Beyond chemotherapies and radiation therapies, growing evidence indicates that p53-mutant tumor...

  • Review
  • Open Access
9 Citations
6,738 Views
25 Pages

Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes

  • Yue Ma,
  • Natisha R. Field,
  • Tao Xie,
  • Sarina Briscas,
  • Emily G. Kokinogoulis,
  • Tali S. Skipper,
  • Amani Alghalayini,
  • Farhana A. Sarker,
  • Nham Tran and
  • Deborah J. Marsh
  • + 2 authors

3 September 2024

SWI/SNF (SWItch/Sucrose Non-Fermentable) is the most frequently mutated chromatin-remodelling complex in human malignancy, with over 20% of tumours having a mutation in a SWI/SNF complex member. Mutations in specific SWI/SNF complex members are chara...

  • Systematic Review
  • Open Access
3 Citations
3,053 Views
26 Pages

Impact of Physical Activity on DNA Methylation Signatures in Breast Cancer Patients: A Systematic Review with Bioinformatic Analysis

  • Chantalle Moulton,
  • Veronica Lisi,
  • Monica Silvestri,
  • Roberta Ceci,
  • Elisa Grazioli,
  • Paolo Sgrò,
  • Daniela Caporossi and
  • Ivan Dimauro

3 September 2024

Breast cancer (BC) continues to significantly impact women worldwide. Numerous studies show that physical activity (PA) significantly enhances the quality of life, aids recovery, and improves survival rates in BC patients. PA’s influence extend...

  • Article
  • Open Access
1 Citations
1,856 Views
12 Pages

Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort

  • Ava Kwong,
  • Cecilia Y. S. Ho,
  • Henry C. M. Leung,
  • Amy W. S. Leung,
  • Chun-Hang Au and
  • Edmond S. K. Ma

3 September 2024

Mutation study for high-risk breast and ovarian cancer (HBOC) has been extensively studied in patients of different ethnicities. Here we compared the germline mutation rate and mutation spectrum of patients (n = 4341) with benign breast diseases or b...

of 4

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694